One major challenge in drug recalls is the timely identification and communication of risks. Often, adverse effects might not be apparent until a significant portion of the population has been exposed to the drug. Additionally, ensuring that all affected parties, including healthcare providers and patients, are informed about the recall can be logistically challenging. The global distribution of pharmaceuticals further complicates the recall process.
